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INTRODUCTION 
 
          Snake bite is a preventable public health hazard in tropical and subtropical 
countries. India has always been a land of exotic snakes, which has a warm climate and 
dense vegetations. 
 
          The causes of renal failure in snake bite are hypotension, bleeding, DIC, direct 
nephrotoxicity of the snake venom and myoglobinuria. Rhabdomyolysis is a common 
cause of renal failure in sea snakes. Even though there is a high incidence of myonecrosis 
in haemotoxic snake bites, there are no extensive studies done on myonecrosis in 
haemotoxic and neurotoxic snake bites and its correlation with renal failure. 
 
          Better understanding of the problem is essential for the prevention and therapeutic 
measures to reduce if not eradicate the morbidity and mortality from snake bite. 
 
 
 
 
 
 
 
 
 
 2
REVIEW OF LITERATURE 
EPIDEMIOLOGY 
  
           There are about 3500 species of snakes in the world. Of these 216 species of 
snakes are found in India, of which 52 species are poisonous. It is widely agreed that 
India contributes the largest share to the annual worldwide mortality due to snake bite. 
Mortality figures have ranged widely from 15000 to 40000 per year. Population based 
studies put an annual death rate of one in 10000 in the early 20th century and 3.1 per 
100,000 in the 1950s. As snake bite is predominantly a rural problem and its reporting is 
very variable, estimating the magnitude of the problem is purely conjectural. 
 
           The circumstances of the bite and clinical development permit a good guide as to  
the species involved. Krait bites are usually nocturnal, indoor, unprovoked and painless. 
Cobra and viper bites are painful and accompanied by neuroparalysis and coagulopathy 
respectively. Bites by sea snakes occur mostly in the coastal areas and usually amongst 
the fishermen. Immunological methods for snake venom identification are not used in 
India despite having been established for several years elsewhere. Most bites are in the 
limb that are most used in the victim’s occupation.   
    
           Cobra and krait are found all over India, the Russell’s viper is more prevalent in 
the south and the saw scaled viper is more commonly found in the north and the west. 
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            In India highest incidence is reported from Tamilnadu, Kerala, West Bengal, 
Maharashtra and Uttar Pradesh. No age group is exempted and males are more affected 
because of their frequent out door occupation 
 
SCENERIO OF SNAKES 
  
Common poisonous snakes encountered are 
            1.    Elapidae – Cobra, krait, mamba and tiger snake. 
2.  Viperidae – Russell’s viper, saw scaled viper, gaboon viper and puff adder. 
            3.   Crotalidae – Rattlesnakes, pigmy rattlesnakes, pit viper and cottonmouths. 
            4.   Hydrophidae – Sea snakes.  
            5.   Colubridae – Boom slangs, bird snake of the African continent. 
 
        One can identify a poisonous snake by means of the following features: 
A) Belly scales: Large and cover the entire breadth.  
B) Head scales: 
              1)   Small in viper 
2) Large and conspicuous pit between the eye and nostril in pit viper. 
3)   Third labial touches the eye and nasal shield in cobra. 
4) No pit and third labial does not touch the nose and eye and central row of 
scales on back enlarged; undersurface of the mouth has only four 
infralabials, the fourth being the largest ( krait ). 
C) Fangs:  hollow like hypodermic needle.                                                                                                                                      
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D) Tail:  compressed 
E) Habits:  nocturnal 
F) Teeth:  two long fangs 
   
ELAPIDAE 
 
            The cobra has a hood which on dorsal side bears a double or single spectacle 
mark, but it has sometimes an oval spot surrounded by an ellipse. The hood cannot be 
seen in a dead cobra, as the joints and neck become stiff. There are two black spots, and 
three black bands on the undersurface of the hood. There is a white band in the region 
where the hood touches the body region. The colour is brown or black. The king cobra 
has a hood, but no mark on it, and the length of king cobra is about three to four metres. 
The colour may be yellow, green, brown or black and has yellowish or white cross-bands 
in the body. 
 
            In kraits, the body is either steel blue with white cross bars or white cross spots 
(common kraits) or yellow body with black cross bars and a black stripe across the face 
(banded krait). 
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 VIPERIDAE 
 
          Russell’s viper has a flat, heavy and triangular head with a white V-shaped mark, 
the angle of the V pointing forwards. It has three rows of diamond shaped black or brown 
spots along the back, the outer two rows consisting of spots ringed with white edges. Its 
body is whitish with dark semilunar spots. It narrows towards its tail, which is short. It 
can be identified by the entire broad plates on the belly, the small scales on the head and 
the shield beneath the tail divided into two rows. 
 
          The saw-scaled viper is brown and has wavy white line on each flank of the back 
with diamond shaped areas between these two lines. It has a triangular head, the upper 
surface of which is covered with a white mark resembling an arrow. The tail is short and 
tapering. The broad belly plates with brown or dark spots, small scales on the head and 
entire shields beneath the tail are the distinguishing features. 
 
SEA SNAKES 
 
        They have small eyes, prominent nostrils on the top of the head, broad ventrals, 
small tuberculated dorsal scales and paddle shaped flat tails. They are black, greenish-
black or bluish-black with or without bands.   
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ANATOMY OF SNAKES 
 
        They have elongated body without any appendages. The tapering part of body has 
greater capacity to move and is called the tail. They have eyes with round and vertical 
pupils without eyelashes. 
 
        The lower jaw has a pair of bones, connected by a firm ligament in the front, and 
remains free without articulating the maxilla. This gives it the power to open the mouth 
widely. 
 
        Poisonous snakes have two teeth called fangs, which are present on the pre-maxilla. 
Duct of the poison gland opens at the base of the teeth one on either side of upper jaw 
below the orbit. Anteriorly the gland opens into a narrow venom-duct which ends in an 
ampulla like dilatation at the base of the fangs. 
 
SNAKE VENOMS 
 
       According to the systems mainly affected by the snakes, the snakes are divided into   
1) Neurotoxic :  Cobra, King cobra, Krait 
2) Haematotoxic :  Russell’s viper, Pit viper 
3) Myotoxic :  Sea snakes  
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       It is essential to understand the pharmacological action of snake venom in order to 
device rational treatment for snake bite. A single snake may contain several varieties of  
poison. Important effects are produced in the heart, nervous system, blood vessels, blood, 
kidneys and the respiratory system. The conduction along the nerves and paralysis of the 
neuro-muscular junctions are the main effects on the nervous system.  
 
      The previous concept of classifying the snake venom as  1) Neurotoxins 2) 
Haemotoxins 3) Cardiotoxins and 4) Myotoxins would not hold true because of 
combination of toxins present in the venom. Venom are complex of peptides, 
polypeptides, enzymes, glycoproteins and other substances capable of producing  several 
pharmacological actions which may also contain inorganic substances – sodium, 
potassium, calcium, zinc, manganese, etc. Zinc ions are essential for anti-cholinesterase 
activity. Calcium may play a role in activation of phospholipase A and the direct 
hemolytic factor. The more lethal fraction of snake venom appears to be peptides and 
certain non-enzymatic proteins. 
 
ENZYMES 
 
      The snake venom has several enzymes. 26 such enzymes have been identified but no 
single snake venom contains all of them. Elapidae contains esterase that hydrolyse 
carbonomethoxy choline and also rich in acetylcholinesterase. Viper lacks these enzymes 
but are rich in endopeptidase, proteolytic enzymes, arginine ester hydrolase, thrombin 
like enzymes, collagenase, hyaluronidase and phospholipase. 
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PROTEOLYTIC ENZYMES 
 
a) Proteinase -  abundant in viper venom and cause marked tissue damage and 
destruction. The anticoagulant effect of several snake venoms may be attributable 
in part to the proteolytic disintegration of fibrinogen. The coagulant effect of 
venom may be due to conversion of prothrombin to thrombin, catalysed by the 
proteinases. 
 
b) Hyaluronidase A -  is present in almost all snake venom. It hydrolyses the 
hyaluronic acid and decrease the connective tissue viscosity and allows the 
penetration of another toxin into the surrounding tissues. It is related to the 
edema, swelling and rapid absorption of the toxin at the site of bite. 
 
c) Phospholipases  ( A and B ) - act as catalysts in the hydrolysis of lipids. 
Phospholipase A ( Direct Lytic Factor ) is   responsible for the haemolytic effects 
of snake venom by their direct hydrolyzing effect on phospholipids of red cell 
membrane and indirectly by producing hemolytic agents ( eg- lysolecithin ) from 
plasma lecithin. 
 
d) Phospholipase B - hydrolyse the lysophosphatides 
 
e) Phosphodiesterase -  found in the venom of all poisonous snakes. It attacks 
DNA, RNA and arabinose. 
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f) Arginine ester hydrolase -  present in viper venom; coagulant in effect and 
release bradykinin. 
g) Collagenase -  a specific kind of proteinase that digests collagen. 
 
POLYPEPTIDES 
        These are low molecular weight peoteins without enzymatic activity. 
a) Cobra toxin : 
        They have neuromuscular blocking properties; also have cardiotoxic, haemotoxic 
and anticoagulant activities. Post synaptic neurotoxins are the principal lethal factor of 
cobra venom.  
        Cobra toxin leads to  
                  -    blockage of  neuromuscular transmission 
- blockage of  axonal conduction  
- membrane depolarization  
- hemolysis 
- cytotoxic action  
- cardiac arrest   
        The cardiotoxin cause profound circulatory collapse with cardiac depression and 
peripheral collapse; hypotension and sudden death by cardiac arrest. 
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b) Haemorrhagins ( HR-1 and HR-2 ) :  
        Two immunologically distinct non-enzymatic principles ( HR-1 and HR-2 ) are 
typical components of viper venoms. In severe envenomation, the haemorrhagins play the 
major lethal role by causing haemorrhage into the vital organs – brain, lungs, kidneys, 
heart, GI tract, etc. 
 
        They cause severe vaso-constriction followed by vasodilatation of the micro-vessels 
and the arterioles with haemorrhages in the capillary bed. The vessels revealed 
endothelial gaps due to disintegration of the endothelial cells with intracellular oedema, 
swollen mitochondria and dilated endoplasmic reticulum, separation of the intercellular 
junction of the endothelial cells and focal loss of basement membrane of the vessels, 
leading to capillary and venous haemorrhages in the tissues. 
 
        The haemorrhagins act by directly disrupting the endothelial lining and by inhibiting 
platelet aggregation. This haemorrhgic principle also induces autocrine agents such as 
histamine, serotonin from tissues which open up the endothelial cell junction. HR-1 
exhibits the highest haemorrhagic activity among the haemorrhagins. 
 
OTHER TOXINS 
 
          -the snake venom protein can act either as procoagulants or anticoagulants. 
          -the snake venom can also be myotoxic causing rhabdomyolysis. 
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CLINICAL MANIFESTATIONS 
           The symptoms and signs of snake venom poisoning are dependent upon a number 
of factors. 
 
1) AGE AND GENERAL HEALTH OF THE PATIENTS : 
           Younger patients are at a greater risk because of higher concentration of venom in 
relation to body volume of distribution. Children and elderly patients are alike and more 
likely to succumb easily because of  poor general health.  
 
2) NATURE, LOCATION, DEPTH AND NUMBER OF BITES : 
           Deeper the bite and more the number of bites, it is likely to be more lethal. Direct 
injection into a blood vessel will lead to rapid dissemination of venom and severe 
systemic envenomation. Bite through clothing is less dangerous than bite on a bare limb. 
Bite over an ulcerated area is more risky than over normal skin.  
 
3) AMOUNT OF VENOM INJECTED : 
           This depends on the conditions of fangs and venom glands, amount and kind of 
clothing through which the fangs pass and factors that motivate the snake. 
 
4) SPECIES OF THE SNAKE INVOLVED : 
           This will decide the symptomatology. If the snake can be identified, much of the 
signs and symptoms can be predicted and managed accordingly. 
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5) CONDITION OF THE VENOM GLANDS : 
           The size of the secretory cells and their contents in venom glands vary with the 
different stages of the secretory cycle. The rate of replenishment of the various venom 
components vary. 
 
6) PATIENT’S SENSIVITY TO THE VENOM : 
           It will vary from person to person. Anaphylactic shock can occur in a person 
repeatedly bitten by snakes.  
 
7) PATHOGENS PRESENT IN THE SNAKE’S MOUTH :  
           These are usually anaerobic and gram negative organisms. Anaerobic infection 
will be indicated by a foul smell. 
 
CLINICAL FEATURES OF SNAKE BITE : 
 
           The symptoms and signs of snake bite result from fear, the venom and from 
treatment. Many patients anticipate a rapidly fatal outcome and the clinical picture may 
be dominated by physiological manifestations of anxiety or even frank hysteria. Non-
envenomed patients may complain of  feeling flushed, dizzy and breathless, may feel 
constriction in the chest, palpitations, tingling and spasm of the extremities resulting from 
hyperventilation.                                                                          
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           Harmful effects may result from faulty first aids, traditional remedies, from tight 
tourniquets leading to congested and ischemic limbs, profuse bleeding and sensory loss 
from local incisions, etc. 
 
SIGNS AND SYMPTOMS OF ELAPIDAE BITE 
 
        Elapid venoms are best known for their neurotoxicity. Local effects are minimal in 
krait, but with cobra bite, cellulitis and regional adenitis may occur. There will be 
salivation and vomiting initially. Earlier symptoms to occur before ptosis are contraction 
of frontalis muscle, blurred vision, paraesthesia around the mouth, hyperacusis, dizziness, 
vertigo, signs of autonomic disturbances such as hyperventilation, congested conjunctiva 
and goose flesh. Roughly after 15 minutes to 2 hours the signs will start occurring. 
 
        First detectable paralysis are ptosis and external ophthalmoplegia, because these 
muscles are sensitive to neuromuscular blockade. Later the palate, jaw, tongue, vocal 
cords, neck muscles and muscles of deglutition may become paralysed. Respiratory arrest 
may be precipitated by obstruction of the upper airway by the paralysed tongue. 
Intercostal muscles are affected before the limbs, diaphragm and superficial muscles. 
Loss of consciousness and generalized convulsions are usually explained by hypoxemia 
in patients with respiratory paralysis. Patients also suffer from headache, malaise and 
generalized myalgias. Intractable hypotension may occur in envenomation with Asian 
cobra. 
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SIGNS AND SYMPTOMS OF VIPERIDAE BITE 
 
        Haemorrhagic manifestations are the primary features in viper envenomation. 
Common clinical presentations are  
1)  Local: Cellulitis, blebs, blisters, gangrene, necrosis, bleeding from site, ulcer. 
2)  Systemic manifestations: 
                -circulatory failure 
                -regional lymphadenitis 
                -spreading cellulitis   
                -oliguria, anuria 
                -myoglobinuria 
3)  Haemorrhagic manifestations:   
                -hematuria 
                -gum bleeding 
                -epistaxis 
                -haemoptysis  
                -hemetemesis 
                -malena 
                -intracerebral bleeding 
                -sub arachnoid bleed 
                -sub conjunctival haemorrhage 
                -retinal haemorrhage 
                -retroperitoneal, intraperitoneal haemorrhage    
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     Overt signs of hemolysis like hemoglobinuria or jaundice, are reported in Australian 
land snakes. 
 
SIGNS AND SYMPTOMS OF SEA SNAKE BITE 
 
        There will be minimal local signs. After one or two hours, generalized pain and 
stiffness develop. Release of myoglobin, muscle enzymes and potassium leads to brown 
or pinkish discolouration of urine. Respiratory failure may occur.                 
 
PATHOGENESIS OF ACUTE RENAL FAILURE  IN SNAKE BITE 
 
           The exact pathogenesis of ARF following snake bite is not well established. 
However, a number of factors may contribute viz. bleeding, hypotension, circulatory 
collapse, intravascular hemolysis, disseminated intravascular coagulation, myoglobinuria, 
microangiopathic hemolytic anemia and also direct nephrotoxicity of the venom. 
 
HYPOTENSION 
 
          Bleeding either into tissues or externally, and loss of plasma into the bitten 
extremity can produce hypotension and circulatory collapse. This is caused by venom 
metalloproteinases that degrade basement membrane proteins surrounding the vessel 
wall, leading to loss of integrity. Hemorrhagic toxins have been isolated from venom of 
many snakes of Viperidae and Crotalidae families.  Additionally, vasodilatation and 
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increased capillary permeability, both as a result of direct and indirect effects of venom, 
can aggravate the circulatory disturbances of shock. Vipera palestinae venom is thought 
to cause shock by depression of the medullary vasomotor center. Bitis arietans causes 
hypotension by a combination of myocardial depression, arteriolar vasodilation and 
increased vascular permeability. Irrespective of the cause, hypotension and circulatory 
collapse set in motion a chain of hemodynamic disturbances, which are known to 
culminate in ischemic ARF. 
 
INTRAVASCULAR  HEMOLYSIS 
         Another factor thought to have pathogenetic significance in snake-bite-induced 
ARF is intravascular hemolysis.  Hemolysis results from the action of phospholipase A
 2 
which is present in almost all snake venoms, and a basic protein called "direct lytic 
factor", found only in elapid venoms.  Phospholipase A
 2 causes hemolysis by direct 
hydrolysis of red cell membrane phospholipids or indirectly via the production of the 
strongly hemolytic lysolecithin from plasma lecithin. Evidence of intravascular hemolysis 
in the form of anemia, jaundice, reticulocytosis, raised plasma free hemoglobin, abnormal 
peripheral blood smear, and hemoglobinuria is present in about 50% of patients following 
bites by the Russell's viper and Echis  carinatus. 
 
DISSEMINATED INTRAVASCULAR COAGULATION 
         The human hemostatic system is regulated via a number of critical interactions 
involving blood proteins, platelets, endothelial cells, and sub-endothelial structures. 
Snake venom proteins and peptides are known to activate or inactivate many of these 
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interactions. Snake venoms, particularly those from the viper and pit viper families, 
contain many proteins that interact with members of the coagulation cascade and the 
fibrinolytic pathway. 
 
         Russell's viper venom (RVV) contains a factor V-activating serine proteinase(RVV-
V),  which has been separated from a factor X-activating protein, also present in this 
venom. RVV-V cleaves a single peptide bond to convert factor V to factor V
 a (the 
activated clotting protein). Russell's viper venom also contains a potent activator of 
human coagulation factor X; this enzyme has been well characterized and is designated 
as RVV-X. Russell's viper venom also activates factor IX by cleavage of a single peptide 
bond resulting in the formation of factor IXa.  
 
         The enzymes present in snake venom can act as direct prothrombin activator and do 
not require calcium ions, phospholipids or factor V. It is apparent that the activation 
mechanism catalysed by the venom enzyme differs from the physiological mechanism of 
prothrombin activation. One or two peptide bonds are cleared by the venom enzyme 
during activation, generating a catalytically active intermediate. This intermediate is 
converted autocatalytically to normal thrombin. 
 
         Although thrombin has many activities, the ability of some snake venom enzymes 
to clot fibrinogen has resulted in these enzymes being called "thrombin-like". These are 
widely distributed primarily in the venom of snakes from true vipers and pit vipers. 
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Snake venom fibrinogen clotting enzymes have been classified into several groups based 
on the rates of release of fibrinopeptides A and B from fibrinogen. 
 
         One mechanism of the anticoagulant action of snake venom proteins is attributed to 
the activation of protein C. Activated protein C degrades factors V
 a and VIII a and 
therefore, has anticoagulant activity. Another mechanism of anticoagulation involves 
inhibition of blood coagulation factors IX and X by a venom protein(s) that binds to 
either or both. Finally, anticoagulation is also achieved through the action of snake 
venom phospholipases that degrade phospholipids involved in the formation of 
complexes critical to the activation of the coagulation pathway.  
 
        Direct-acting fibrinolytic enzymes have also been isolated from the venom of 
snakes. Snake venom also contains a number of platelet active components, including 
those that cause platelet aggregation and those that inhibit platelet aggregation.  
 
        The final coagulation disturbance depends upon the balance among the activity of 
procoagulant, anticoagulant, fibrinolytic and fibrinogenolytic components of injected 
venom. The presence of fibrin thrombi in the renal microvasculature and in the 
glomerular capillaries, and the findings of microangiopathic hemolytic anemia and 
thrombocytopenia in patients with cortical necrosis strongly suggest that DIC plays a 
major pathogenetic role in snake-bite induced cortical necrosis. Snake venom initiates a 
chain reaction involving the coagulation, fibrinolytic, kinin and complement systems. 
Venom-induced alterations lead to vascular coagulation and to deposition of fibrin 
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thrombi in blood vessels. Intraglomerular fibrin deposition of lesser degree has been 
suspected as causing acute tubular necrosis via a temporary hemodynamic alteration. 
DIRECT   NEPHROTOXICITY       
        Snake venom  can cause direct nephrotoxicity and the  strongest evidence supporting 
direct nephrotoxicity is a dose-dependent decrease in inulin clearance and an increase in 
fractional excretion of sodium in the isolated perfused rat kidney, following Russell's 
viper envenomation. 
 
MYOGLOBINURIA 
        The destruction of skeletal muscle and the release of muscle cell contents, notably 
myoglobin, into the circulation can cause an acute deterioration in renal function.Muscle 
damage from non-traumatic as well as traumatic causes can produce the syndrome of 
myoglobinuric acute renal failure(ARF), thus establishing rhabdomyolysis as a common 
cause of ARF on medical and surgical services of large hospitals. 
 
        A variety of conditions and diseases can lead to rhabdomyolysis and ARF. Although 
the list is lengthy ,it can be divided into eight basic categories 1) direct muscle injury,2) 
drugs & toxins-“snake venom”,3) genetic disorders causing decreased energy 
production,4) infections,5) excessive muscular activity,6) ischemia,7) electrolyte & 
endocrine/metabolic disturbances and 8) immunological diseases. The common 
denominator for all these causes is a disruption of normal skeletal muscle structure and 
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/or metabolism that leads to cell death and lysis  with resulting release of intracellular 
contents into circulation. 
 
MYOGLOBIN METABOLISM 
 
        Myoglobin is composed of a folded polypeptide portion(globin)  and a prosthetic 
group, heme, which contains an atom of iron. The molecular weight of myoglobin is 
17,800 daltons, which is approximately one-fourth that of the other major heme pigment, 
hemoglobin. The half-life of myoglobin in the circulation varies from 1 to 3 hours; after 6 
hours, it has completely disappeared. Small quantities of myoglobin released during 
normal conditions are probably cleared by reticuloendothelial system. Larger quantities 
of myoglobin released from muscle in states of injury or disease are readily filtered at the 
glomerulus and thus can be cleared by renal mechanisms. 
          
        In the human circulation, myoglobin appears to be bound to an alpha-2 globulin that 
has a binding capacity of 23 mg/dl. Because myoglobin is only  loosely bound to this 
alpha-2 globulin, at concentrations below 23 mg/dl, approximately 15% to 50% of the 
myoglobin is in an unbound state and is filtered (fractional clearance relative to 
inulin,0.75) and excreted in the urine. This interesting kinetic relationship between 
myoglobin and its binding protein probably explains why myoglobin is detected in the 
urine when plasma levels are less than 23 mg/dl. The effective renal threshold for 
myoglobin occurs when the plasma concentration exceeds 0.5 to 1.5mg/dl. 
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        Although the presence of myoglobinemia or myoglobinuria is indicative of skeletal 
muscle injury, it may not be the most sensitive method to detect rhabdomyolysis. Given 
that myoglobin has a relatively rapid renal clearance (1 to 6 hrs), a patient  with 
rhabdomyolysis may have a normal plasma level by the time he or she is hospitalized. In 
contrast , creatine kinase ,an intracellular muscle enzyme, appears to be a more sensitive 
plasma marker for rhabdomyolysis because of its slower clearance (serum half-life 1.5 
days). Thus, at initial clinical evaluation, patients with rhabdomyolysis will have 
increased serum creatine kinase levels, whereas urinary myoglobin levels may or may not 
be detected. 
 
PATHOPHYSIOLOGY OF MYOGLOBINURIC ACUTE RENAL FAILURE 
 
        The exact pathophysiology of pigment-induced ARF is unclear and is probably 
multifactorial. The proposed mechanisms by which myoglobinuria cause ARF include 
hypovolemia and renal ischemia, direct tubular toxicity of myoglobin, tubular obstruction 
from heme pigment casts and /or uric acid crystals, and glomerular fibrin deposition. As 
in many clinical syndromes, it is probably the interplay of these proposed mechanisms 
that results in ARF, rather than any one single factor. 
 
HYPOVOLEMIA AND RENAL ISCHEMIA 
 
        During the initial phase of myoglobinuria induced ARF, there is a marked reduction 
in cardiac output(36%) and renal blood flow (20%) and an increase in renal  vascular 
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resistance. The hemodynamic changes are due, in part, to the migration of plasma water 
into the sites of injury, with consequent severe intravascular  volume contraction. The 
reduction in renal blood flow is associated with a redistribution of regional blood flow 
from the outer to the inner cortex and vasoconstriction of the afferent and efferent 
arterioles. The proposed mediators of this initial renal vasoconstriction include increased 
sympathetic nerve activity, augmented activity of the renin angiotensin system, reduced 
nitric oxide production, suppressed renal prostaglandin production, increased plasma 
vasopressin concentration, and formation of glomerular  microthrombi. The renin 
angiotensin system is probably not a major factor  in the pathogenesis of  myoglobinuric 
ARF, and the studies evaluating the other listed mediators do not provide definitive 
evidence of their causal role. Thus, the exact mediators have not been established, and the 
renal vasoconstriction may be due to the interplay among a number of vasoconstricting/ 
vasodilating systems. 
 
MYOGLOBIN NEPHROTOXICITY 
 
        Myoglobin is a direct nephrotoxin and is highly nephrotoxic in the setting of 
acidemia / aciduria and volume depletion. In an acidic medium (Ph<5.6) myoglobin 
dissociate into ferrihemate (hematin, molecular weight 670 daltons) and their respective 
globin moieties. After filtration by the glomerulus, myoglobin dissociates to ferrihemate 
and globin in the presence of an acid tubular fluid, or after exposure to the acid pH of 
cellular lysosomes, and it is the ferrihemate compound that is directly nephrotoxic. 
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       Heme moiety is the nephrotoxic factor in myoglobinuric-induced ARF and the iron 
component of heme may be the specific culprit in causing renal injury. Iron can promote 
hydroxyl free radical  formation by the Fenton-Haber-Weiss reaction, leading to lipid 
peroxidation and cell necrosis. Myoglobin can act as Fenton reagent. 
  
       The kidney may have its own system to contend with exposure to iron containing 
heme pigments. Normally, iron is released from heme by the rate limiting enzyme heme 
oxygenase, which acts by opening up the heme ring, generating iron and biliverdin. In 
turn, the liberated iron molecule can be taken up by ferritin, the major cellular repository 
for iron. The renal production of both heme oxygenase and ferritin is increased in the 
myoglobinuric ARF. The increase in heme oxygenase and ferritin production is proposed 
to be an adaptive response on the part of the kidney upon exposure to heme pigments and 
is a mechanism by which the kidney normally will degrade heme and sequester the 
potentially nephrotoxic iron 
 
TUBULAR OBSTRUCTION 
         
        Filling of the tubular lumen by pigment casts that become inspissated and obstruct 
urinary blood flow with subsequent injury to tubular epithelium is one of the mechanisms 
proposed to explain the nephrotoxicity of the heme pigments. Hypovolemia and acidemia 
and the concomitant acidic concentrated urine facilitate precipitation of filtered 
myoglobin, leading to obstructive cast formation. In addition, it has been speculated that 
the increased urinary uric acid concentration observed in rhabdomyolysis may result in 
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uric acid precipitation in the tubules. Tubular obstruction can decrease GFR either by 
increasing the tubular pressure and thus decreasing the glomerular transcapillary 
hydraulic pressure or by inducing the release of factors (e.g., thrombaxane) that cause 
renal vasoconstriction, thereby reducing glomerular blood flow. 
 
        Although there is evidence that tubular obstruction may be a factor in the 
pathogenesis of the ARF, it is probably not the primary cause of the initial decrease in 
GFR in myoglobinuric – induced ARF. The presence of casts is the result , rather than the 
cause, of the decrease in GFR and urine flow. Instead of causing the initial decrease in 
renal function, casts formation may play a role in the maintenance of the renal failure 
once it develops. 
 
GLOMERULAR FIBRIN DEPOSITION. 
         
        Due to the liberation of tissue factors, both rhabdomyolysis and intravascular 
hemolysis can initiate disseminated intravascular coagulation(DIC). Fibrin strands have 
been deposited in glomeruli. Myoglobin per se is not the cause of the renal damage, but 
rather it is the release of other muscle constituents which induces DIC and the subsequent 
deposition of glomerular microthrombi that is responsible for rhabdomyolysis-induced 
ARF. 
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LABORATORY FEATURES OF  MYGLOBINURIC  ACUTE RENAL FAILURE 
 
URINE ANALYSIS 
 
        Examination of the urine provides the first laboratory clue to the presence of 
myoglobinuria. Classically, the initial urine is dark in color, usually with an acid pH; the 
benzidine  or orthotoluidine reagent will give a positive reaction for blood(3+ to 4+), but 
microscopic examination of the urinary sediments fails to reveal any red blood 
cells(RBC’s) or at best , only a few (<5 per HPF) indicating the presence of a heme 
pigment not contained within RBC’s. But urinary myoglobin levels are not the most 
sensitive clinical marker for rhabdomyolysis. 
 
SERUM POTASSIUM 
 
        The most life threatening consequence of rhabdomyolysis is the release of large 
amounts of intracellular potassium into the circulation. Since more than 98% of total 
body potassium resides within cells and skeletal muscle represents 60 to 70% of the total 
cellular mass, breakdown of even a small area of skeletal muscle will release a 
considerable potassium load. The presence of acidosis may shift potassium 
extracellularly and worsen the hyperkalemia. Admission serum potassium levels tend to 
be higher in patients who go on to develop ARF. About half of an acute potassium load is 
handled by renal excretion; therefore, in ARF, serious hyperkalemia can result and is 
usually the major indication for dialysis. 
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CREATINE KINASE 
        The relatively slower clearance of creatine kinase compared  to myoglobin makes 
this enzyme level a more sensitive marker of muscle injury. Although no correlation has 
been established between the absolute level of the creatine kinase and the risk for the 
development of  ARF, creatine kinase levels are significantly higher in the patients who 
develop ARF. Following serial serum creatine kinase levels  is key to monitoring patients 
with rhabdomyolysis in as much as the concentration of creatine kinase may continue to 
increase after admission to hospitals, reflecting ongoing or worsening muscle necrosis. 
Increasing or decreasing creatine kinase concentrations  provide some insight into 
whether the rhabdomyolysis is worsening  or resolving. 
 
ACID BASE BALANCE 
        The conditions that cause rhabdomyolysis involve tissue trauma and/or ischemia and 
predispose the patient to an augmented acid load. An elevated serum anion gap is usual in  
patients with rhabdomyolysis and is due to impaired renal excretion of intracellular 
organic acids released from damaged muscles, as well as retention of  inorganic anions 
such as phosphate. 
 
URIC ACID 
        Hyperuricemia is expected in patients with rhabdomyolysis . The increase in uric 
acid levels is due to the release of intracellular purines from damaged muscle cells, which 
are converted to uric acid in the liver. 
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BUN/ CREATININE RATIO 
 
        The rate of rise of serum creatinine relative to the rise in blood urea nitrogen (BUN) 
is often disproportionately greater in rhabdomyolysis-induced ARF compared to other 
causes of ARF. This phenomenon has been attributed to the release of larger quantities of 
creatine from damaged muscles and the subsequent conversion of the creatine to 
creatinine, resulting in a more rapid increase in serum creatinine concentration. 
 
CALCIUM- PHOSPHORUS METABOLISM 
 
        The perturbations of calcium and phosphorus metabolism that are usually seen in 
most types of ARF appear to be exaggerated in rhabdomyolysis-induced ARF. Muscle 
damage leads to breakdown of intracellular phosphate compounds and release of large 
quantities of inorganic phosphorus  into the circulation, resulting in hyperphosphatemia. 
This abnormality is accentuated when ARF impairs urinary phosphate excretion. 
Hypocalcemia  also occurs early in the course of myoglobinuric ARF due to the 
deposition of calcium salts in the damaged muscles(dystrophic calcification). 
 
        Hypocalcemia  may also be due to abnormalities of vitamin D and parathyroid 
hormone metabolism. Very low levels of 1,25- dihydroxycholecalciferol and high levels 
of parathyroid hormone have been noted during the oliguric phase of myoglobinuric-
induced ARF. This may be due, in part, to the hyperphosphatemia associated with 
rhabdomyolysis in as much as hyperphosphatemia has been demonstrated to reduce renal 
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synthesis of vitamin D and stimulate the production of PTH. Regardless of mechanism, in 
the absence of frank tetany, hypocalcemia usually does not require treatment. In fact, 
correction of hypocalcemia with vigorous intravenous calcium replacement may increase 
both dystrophic and metastatic calcification.  
 
        Approximately 20%-30% of patients with  myoglobinuric ARF will develop 
transient hypercalcemia, during recovery (diuretic) phase of their ATN. It may be due to 
augmentation of normal remobilization of the calcium deposits in the injured muscle, 
which occurs during the recovery phase of ARF. Alternatively, it has been proposed that 
as renal function improves, the combination of a decreasing serum phosphorus 
concentration and the ambient secondary hyperparathyroidism will stimulate the 
synthesis of vitamin D resulting in an “over shoot” hypercalcemia. This augmented 
vitamin D production may be due, in part, to release of vitamin D from damaged muscles. 
 
URINARY SODIUM EXCRETION 
 
        In myoglobinuric-induced ARF, a low fractional excretion of sodium (< 1%) is 
observed. Hypovolemia and renal ischemia are important factors in the development of 
renal failure in myoglobinuric ARF and the increased sodium avidity may be due to the 
renal hypoperfusion. In addition to this mechanism , it is known that tubular obstruction 
may be a contributing factor for augmented sodium reabsorbtion. It is important to note 
that a low fractional excretion of sodium is not seen in all cases of myoglobinuric ARF. 
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DISSEMINATED INTRAVASCULAR COAGULATION(DIC) 
        DIC is commonly present in patients with rhabdomyolysis  and may be due to the 
release of intracellular thromboplastins, that activate the clotting cascade. Moreover, the 
DIC may be a factor in the pathogenesis of ARF. 
 
TREATMENT OF SNAKE BITE 
        Consists of first aid and specific management. 
First aid : 
        -reassure the victim 
        -immobilize the limb with a splint or sling  
        -take the patient to nearby health centre as quickly as possible 
        -snake should be taken for species identification if it has been killed 
        -cauterisation, incision, suction by mouth should be avoided 
        -use of tourniquets is controversial. 
Specific treatment : 
        In areas where immunodiagnostics and monovalent antivenom are available, efforts 
to identify the snake must be made energetically. However this is not the case in India as 
monovalent antivenom is not available. Polyvalent anti snake venom will reverse the 
neuro, haemo and myotoxic effects and their complications. 
 
INDICATIONS  FOR  ASV : 
Systemic envenomation : 
        1) Neurotoxicity – ptosis, ophthalmoplegia, etc 
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        2) prolonged clotting time  
        3) features of  DIC  
        4) spontaneous systemic bleeding 
        5) hypotension ( shock ) 
        6) generalized rhabdomyolysis   
        7) impaired consciousness. 
 
Severe local envenomation : 
        1) extensive local swelling ( involving more than half of the bitten limb ) 
        2) rapidly evolving local swelling ( extending beyond the bitten segment of limb – 
eg., above the ankle in bite of foot ) within one hour of bite 
        3) bites in digits ( fingers, toes ) where venom is known to cause necrosis. 
 
DOSAGE OF ASV :       
FOR VIPERIDAE BITE : 
        Mild envenomation with local findings like puncture wounds, pain, soft tissue 
swelling confined to the bite site and no systemic findings and laboratory studies are 
normal – 20 to 50 ml of ASV. 
        Moderate envenomation with swelling extending beyond the site of bite, mild 
systemic findings ( nausea, vomiting, muscle fasciculations, paraesthesia ), mildly 
abnormal laboratory findings ( prolonged clotting time, mildly abnormal platelet count or 
fibrinogen, or elevated fibrin split products ) – 50 to 100 ml of ASV. 
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        Severe envenomation with generally severe pain and swelling (may be minimal 
swelling with deep intramuscular or intravenous poisoning ), more severe systemic 
findings ( respiratory distress, hypotension/shock, evidence of bleeding ) and very 
abnormal laboratory parameters – 150 to 200 ml of ASV.  
 
        Spontaneous systemic bleeding usually stops within 30 minutes of ASV and blood 
coagulability is restored within 6 hours of ASV. Doses may be repeated if symptoms 
persists for more than 6 hours of the first dose. It is advantageous to give repeated doses 
of ASV rather than a single dose.  
 
FOR ELAPIDAE BITE :  
        Initial high doses of ASV is recommended – 100 to 150 ml. Neurotoxic signs will 
begin to improve within 30 minutes of ASV therapy. As in viper bite, doses may be 
repeated if symptoms persists for more than six hours of the first dose. 
       
SUPPORTIVE THERAPY :  
        -ventilatory support in cases of respiratory paralysis. 
        -anti cholinesterase drugs ( eg. Neostigmine 50-100 micrograms/kg ) every 4th 
hourly may produce rapid reversal of ptosis, glossopharyngeal palsy 
        -correction of blood loss and hypovolemia 
        -tetanus toxoid 
        -antibiotics to cover gram negative organisms and anaerobes 
        -management of acute renal failure 
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        -fasciotomy for intracompartmental syndrome. 
 
TREATMENT OF MYOGLOBINURIC ARF : 
        Because hypovolemia and renal ischemia are important factors in the pathogenesis 
of myoglobinuric-ARF, it has been recognized that early and vigorous intravenous fluid 
therapy is important in attenuating renal injury. Based on the notion that myoglobin is 
more nephrotoxic at an acidic pH, most groups advocate the addition of sodium 
bicarbonate to the i.v fluids for the purpose of alkalinization of the urine. By correcting 
cellular acidosis, bicarbonate therapy may reduce renal tubular epithelial swelling and 
attenuate renal tubular and vascular collapse. Further, this therapy may ameliorate the 
hyperkalemia commonly seen in rhabdomyolysis. 
 
        Mannitol has long been recognized to be an effective agent in the prophylaxis 
against the development of experimental and clinical ARF and has been used in 
combination with fluid/alkaline therapy to prevent the renal injury in patients with 
rhabdomyolysis. Effects of mannitol include a decrease in blood viscosity and in oncotic 
pressure across the glomerulus to facilitate and increase in GFR, dilatation of glomerular 
capillaries and stimulation of prostaglandin release, increase in urine flow and prevention 
of obstructing cast formation, reduction in renal tubular epithelial swelling and injury, 
and scavenging of oxygen free radicals. In addition, mannitol may have extrarenal benefit 
such as extracellular volume expansion, an increase in cardiac contractility, increased 
release of ANF, and reduction in skeletal muscle edema with consequent decompression 
of muscle tamponade. 
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        Furosemide, a loop acting diuretic, has the theoretic advantage of inhibiting sodium 
transport in the thick ascending limb of Henle’s loop. By inhibiting sodium transport, 
furosemide may reduce oxygen consumption in the face of limited delivery and thereby 
preserve cell viability. In addition, the augmented urinary flow induced by the diuretic 
may mitigate against tubular obstruction. Loop diuretics, however, have the theoretic 
disadvantage of increasing acidification of urine, worsening intravascular volume 
depletion if urinary losses are not replaced, and inducing ototoxicity; thus, the use of 
these agents has not been generally recommended. 
 
        Although there are no controlled trials to show a direct benefit of a forced alkaline-
mannitol diuresis in the prevention of ARF in rhabdomyolysis, there are many case 
reports suggesting such therapy was instrumental in averting renal injury. Initially, 
optimization of intravascular fluid volume deficits should be carried out with dispatch 
using isotonic crystalloid solutions, usually normal saline. Variables useful in following 
this course of therapy include physical examination of the state of the circulation, serial 
measurement of hematocrit, and recording of external fluid balance. If the clinic 
assessment suggests that a euvolemic state has been achieved but no improvement in 
oliguria has occurred, the decision must be made about further intervention. Usually by 
this time, laboratory results will offer further support for the diagnosis of myoglobinuria 
and acute renal insufficiency and the prompt infusion of mannitol-bicarbonate solution is 
recommended. This is made by adding two ampoules, each containing 12.5 g of mannitol 
in 50 ml, and two ampoules of 50 meq of sodium bicarbonate in 50 ml to 800 ml of 5% 
dextrose in water for intravenous infusion. This reconstituted liter is roughly isosmotic 
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with plasma once the glucose is metabolized and contains both mannitol and 100 meq of 
sodium bicarbonate. It should be infused at 250ml/hour; urine flow rate should increase 
by the end of the 4 hour infusion if the treatment is successful. If this is the case, the 
solution should continue to be administered at a rate equal to urine output until such time 
as azotemia has started to clear and all evidence of myoglobinuria has disappeared. If 
urine fiow does not increase after the 4 hour infusion, the patient has entered the 
established phase of oliguric ARF and should be treated conservatively until dialysis can 
be arranged. When ARF has become established, hemodialysis must be done. 
 
        The prognosis for the renal failure is good, but the ultimate prognosis is more 
dependent on other comorbid conditions such as sepsis, bleeding and respiratory failure.         
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AIM OF THE STUDY  
  
1) To study the incidence of myonecrosis in haemotoxic and neurotoxic snake 
bites. 
2) To correlate CPK-MM levels with acute renal failure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 36
MATERIALS AND METHODS  
 
        Patients admitted in the medical wards of Govt. Rajaji Hospital, Madurai formed the 
materials of this study. Totally, 100 patients have been studied. History, clinical findings 
and investigations were written in printed proforma. 
 
INCLUSION CRITERIA : 
 
1) All patients with definite history of snake bite. 
2) Patients above 12 years of age. 
 
EXCLUSION CRITERIA : 
 
1) Chronic kidney disease 
2) Hypotension 
3) Sepsis 
4) Acute coronary syndromes 
5) Patients who had intramuscular injection one week before the snake bite. 
CPK-MM levels are detected using kinetic methods and myoglobinuria is detected using 
spectroscopy. 
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     The levels of CPK-MM are graded for convenience purpose, as given in the following 
table. 
 
 
 
 
 
 
 
 
 
 
STATISTICAL TOOLS : 
       The information collected regarding all the selected cases were recorded in a master 
chart. Data analysis was done with the help of computer using Epidemiological 
Information Package (EPI 2002). 
       Using this software, frequencies, percentage, mean, standard deviation and `p’ values 
were calculated. A `p. value of less than 0.05 is taken to denote significant relationship. 
 
 
 
 
 
CPK MM SEVERITY 
LESS THAN 140 (NORMAL) 
140 -  499 (1+) 
500 – 999 (2+) 
1000 – 1499 (3+) 
1500 – 1999 (4+) 
2000 AND ABOVE (5+) 
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RESULTS 
 
AGE DISTRIBUTION OF SNAKE BITE CASES : 
 
           Table 1 shows the age distribution of 100 snake bite cases. The incidence of snake 
bite cases is more in 20-49 years of  age. The mean age is 34.86 
 
Table 1 
Age Distribution of snake bite cases 
 
Cases 
Age in Years 
No. % 
Less than 20 11 11 
20-29 24 24 
30-39 26 26 
40-49 25 25 
50-59 11 11 
60 & above 3 3 
Total 100 100 
Mean 
S.D. 
34.86 
12.83 
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TYPE OF SNAKE 
     
         Table 2 shows the number of patients bitten due to different types of snakes. Viper 
bite constitute 79%, cobra bite 4%, krait bite 3% and unknown snake bites 14%. 
 
 
Table 2 
Type of Snake 
 
Cases Type of Snake 
No. % 
Viper 79 79 
Cobra 4 4 
Krait 3 3 
Unknown 14 14 
Total 100 100 
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INCIDENCE OF CELLULITIS DUE TO DIFFERENT TYPES OF SNAKES : 
 
           Table 3 shows the incidence of cellulitis due to different types of snakes. 91.1% of 
viper bite causes cellulitis and 50% of cobra bite causes cellulitis. There was no cellulitis 
in krait bite. This difference is statistically significant with a `p’ value of 0.0007. 
 
 
Table 3 
Type of snake and Cellulitis 
 
Cellulitis 
Present Absent 
 
Type of snake 
No. % No. % 
Viper(79) 72 91.1 7 8.9 
Cobra (4) 2 50 2 50 
Krait (3) - - 3 100 
Unknown(14) 10 71.4 4 28.6 
‘p’ 0.0007 
Significant 
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CORRELATION OF CELLULITIS WITH DEGREE OF MYONECROSIS :  
  
            Table 4 shows the correlation of cellulitis with the degree of myonecrosis. Our 
study revealed a direct correlation between cellulitis and the degree of myonecrosis. The 
mean CPK-MM value in patients with cellulitis is 735.5 IU/L and the mean CPK-MM 
value in patients without cellulitis is 94.4 IU/L and this difference is statistically 
significant with a `p’ value of 0.0001.   
 
Table 4 
Correlation of cellulitis with degree of myonecrosis 
 
 
CPK-MM 
 
 
Cellulitis Mean S.D 
 
Present(n=84) 
Absent(n=16) 
 
735.5 
94.4 
 
573.2 
14.9 
 
p 
 
0.0001 ( significant ) 
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INCIDENCE OF MYONECROSIS IN SNAKE BITE : 
 
         Table 5 shows the incidence of myonecrosis in 100 snake bite patients. The 
incidence of myonecrosis in our study was 81%. The mean CPK-MM level is 632.9 IU/L 
and the range being 56 to 2162.  
 
Table 5 
Level of CPK-MM in 100 snake bite patients 
 
Cases CPK MM 
No. % 
Less than 140 (Normal) 19 19 
140-499 (1+) 35 35 
500-999 (2+) 29 29 
1000-1499 (3+) 6 6 
1500-1999 (4+) 3 3 
2000 & above (5+) 8 8 
Total 100 100 
Mean 
S.D. 
632.9 
575.6 
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AGE DISTRIBUTION OF MYONECROSIS IN SNAKE BITE : 
 
               Table 6 shows the age distribution of myonecrosis in 100 snake bite patients. 
Out of 100 patients studied it was noted that the degree of myonecrosis was high in 
patients less than 40 years of age. Table 3 shows the age wise distribution of myonecrosis 
and the difference among the age wise distribution of myonecrosis is statistically 
significant with a `p’ value of 0.0097 
 
Table 6 
Age distribution of myonecrosis in snake bite 
 
CPK MM Age Group 
Mean S.D. 
Less than 20 1048.5 778.8 
20-29 755.3 676.7 
30-39 685 581.2 
40-49 313 261 
50-59 616.3 304.7 
60 & above 406.3 275.9 
'p' 0.0097 (Significant) 
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SEX DISTRIBUTION OF MYONECROSIS IN SNAKE BITE : 
 
           Table 7 shows the sex distribution of myonecrosis in 100 snake bite patients. 
There was no statistically significant difference in the sex wise distribution of 
myonecrosis in snake bite. The mean CPK-MM value in males is 622.2 IU/L and the 
mean CPK-MM value in females is 660.4 IU/L and the `p’ value is 0.878 ( not 
significant) 
 
 
Table 7 
Sex distribution of myonecrosis in snake bite 
 
 
CPK MM Sex 
Mean S.D. 
Males 622.2 565.3 
Females 660.4 611.1 
p 0.878 (Not significant) 
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DEGREE OF MYONECROSIS IN VARIOUS TYPES OF SNAKE BITE : 
 
           Table 8 shows the degree of myonecrosis in various types of snake bite. Our study 
revealed that viper snake bites have a higher degree of myonecrosis with a mean CPK-
MM value of 676.4 IU/L, followed by unknown snake bites with a mean CPK-MM value 
of 624.3 IU/L, which is followed by cobra bite with a mean CPK-MM value of 204.5 
IU/L and the least in krait with a mean CPK-MM value of 100 IU/L. This difference is 
statistically significant with a `p’ value of 0.0126 
 
Table 8 
Degree of myonecrosis in various types of snake bite 
 
CPK MM Type of Snake 
Mean S.D. 
Viper 676.4 574.4 
Cobra 204.5 147.5 
Krait 100 6.9 
Unknown 624.3 636.3 
p 0.0126 
Significant 
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CORRELATION OF THE DEGREE OF MYONECROSIS WITH 
MYOGLOBINURIA 
 
           Table 9 shows the correlation of the degree of myonecrosis with myoglobinuria. 
Our study revealed that there is a direct correlation between the degree of myonecrosis 
and myoglobinuria. The mean CPK-MM value in patients with myoglobinuria is 2028.4 
IU/L and the mean CPK-MM value in patients without myoglobinuria is 477.9 IU/L and 
this difference is statistically significant with a `p’ value of 0.0001 
  
 
Table 9 
Correlation of the degree of myonecrosis with myoglobinuria 
 
 
CPK MM Myoglobunuria 
 
MEAN SD 
Present 
Absent 
2028.4 
477.9 
92.9 
352.9 
p 0.0001 (Significant) 
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CORRELATION OF THE DEGREE OF MYONECROSIS WITH RENAL 
FAILURE : 
 
           Table 10 shows the correlation between the degree of myonecrosis and renal 
failure. The renal failure patients have a higher level of CPK-MM elevation. The mean 
CPK-MM value in patients with renal failure is 2047.8 IU/L and the mean CPK-MM 
value in patients without renal failure is 509.9 IU/L and this difference is statistically 
significant with a `p’ value of 0.0001 
 
 
Table 10 
Correlation of the degree of myonecrosis with renal failure 
 
 
CPK MM Renal failure 
 MEAN S D 
Absent 
Present 
509.9 
2047.8 
410.6 
84.4 
p 0.0001 (Significant) 
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TYPE OF SNAKE BITE AND RENAL FAILURE : 
 
           Table 11 shows the incidence of renal failure caused due to various types of snake 
bite. The incidence of ARF in our study is 8%. Of these 8 patients with renal failure, 6 
were due to viper bite and 2 were due to unknown bite. In our study, 7.6% of viper bites 
have caused renal failure and 14.3% of unknown snake bites have caused renal failure. 
 
Table 11 
Type of snake bite and renal failure 
 
 
Cases of 
Renal Failure Normal 
Type of Snake 
No. % No. % 
Viper (79) 6 7.6 73 92.4 
Cobra (4) - - 4 100 
Krait (3) - - 3 100 
Unknown (14) 2 14.3 12 85.7 
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DISCUSSION  
 
        The age distribution of snake bite in our study shows the age group between 20-49 
years constitute 75% of the snake bite cases. This is related to the outdoor activities of 
this age group. Older people are least involved because of sedentary habits. 
 
        In our study, cellulitis was present in 84% of patients. 91.1% of patients with viper 
bite developed cellulitis, 50% of patients with cobra bite developed cellulitis and there 
was no cellulitis in krait bite. The reason for this prevalence of cellulitis in viper bite is 
because the enzyme metalloproteinase and the proteolytic enzymes are more abundant in 
Crotalidae and Viperidae snakes. These enzymes cause more tissue destruction and 
damage. Proteolytic enzymes produce local changes in vascular permeability leading to 
oedema, blistering, bruising and necrosis. Proteolytic enzymes are present in lesser 
amounts in Elapidae and hence, they cause minimal cellulitis. In a study conducted by 
Philips et al, 73% of patients had cellulitis. In our study, the incidence of cellulitis is 
84%. 
  
        Creatine kinase-MM levels correlates directly with the presence of cellulitis. CPK-
MM elevation is seen only in patients with cellulitis and CPK-MM is not elevated in 
patients without cellulitis. 
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        The incidence of myonecrosis in our study is 81%. A significant proportion of 
patients had only minimal elevation of CPK-MM ( 35% of patients have CPK-MM levels 
less than 500 IU/L ). 29% of patients have CPK-MM levels between 500-999 IU/L. 6% 
of patients have CPK-MM levels between 1000-1499 IU/L. 3% have CPK-MM levels 
between 1500-1999 IU/L and 8% have CPK-MM levels greater than 2000 IU/L. The 
level of CPK-MM elevation is very much low when compared to the CPK-MM elevation 
seen in sea snake bites. The incidence of myonecrosis is higher in our study because of 
the more prevalence of viper in this part of our country. 79% of snake bites in our study 
were due to viper. 
 
        High levels of CPK-MM elevation is seen more in patients less than 40 years of age. 
This may be due to the degree of envenomation and there is no study done correlating the 
age distribution of myonecrosis.  
 
        The degree of myonecrosis is equal in males and females and there is no significant 
statistical difference among the sex wise distribution of myonecrosis. 
 
        CPK-MM elevation is more with viper bite when compared to cobra and krait bites. 
This is because of the greater amount of tissue damage caused by proteolytic enzymes in 
viper bite. Cobra causes minimal cellulitis and hence mild elevation of CPK-MM. There 
are no local effects in krait bite and therefore CPK-MM is not elevated. A significant 
level of CPK-MM elevation is seen in unknown snake bites. This can be explained, that 
most of the unknown bites may be due to viper. 
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       Out of 100 patients, 8 patients developed renal failure. In a study conducted by 
Philips et al, 9% of his patients developed renal failure. In our study, all renal failure 
patients had myoglobinuria. In a study conducted by Philips et al, 60.86% of his had 
myoglobinuria. This can be explained that a different species of viper snake may be 
involved in his study. Neurotoxicity was the commonest sign in his study and 82% had 
external ophthalmoplegia and 77% had ptosis. But, neurotoxicity was not reported in 
viper bites in our study. This explains that a different species of viper snake may be 
involved in his study. 
 
        Myoglobinuria correlates directly with the level of CPK-MM elevation. The patients 
who developed renal failure have greater elevation of CPK-MM. Seven patients have 
levels greater than 2000 IU/L and one patient has a value of 1874 IU/L. This shows that 
there is a definite correlation between the level of CPK-MM elevation and renal failure. 
The mechanism by which rhabdomyolysis causes renal failure are hypovolemia, renal 
ischemia, direct nephrotoxicity of myoglobin, tubular obstruction from heme pigment 
casts/ uric acid crystals and DIC. 
 
        Although the presence of myoglobinemia or myoglobinuria is indicative of skeletal 
muscle injury, it may not be the most sensitive method to detect rhabdomyolysis. As 
myoglobin has a relatively rapid renal clearance( 1-6 hours ), a patient with 
rhabdomyolysis may have a normal plasma level by the time he or she is  hospitalized. In 
contrast, creatine kinase, appears to be a more sensitive plasma marker for 
rhabdomyolysis because of its slower clearance( serum half-life 1.5 days ). Thus, at initial 
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clinical evaluation, patients with rhabdomyolysis will have increased serum creatine 
kinase levels, whereas urine myoglobin levels may or may not be detected. 
 
        This study indicates the importance of myonecrosis in haemotoxic/ neurotoxic snake 
bite as a cause of snake failure. There are no extensive studies done correlating the 
myonecrosis in haemotoxic/ neurotoxic snake bite and renal failure.  
                
        Limitations of this study are 1) direct nephrotoxicity of the snake venom could not 
be excluded. 2) DIC as a cause of renal failure could not be excluded as DIC is 
commonly seen in rhabdomyolysis.  
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CONCLUSION 
 
1) The incidence of myonecrosis in haemotoxic/ neurotoxic snake bite in our study is 
81%. There is high incidence of myonecrosis in our study. 
2) Viper and cobra bites are definitely associated with myonecrosis. Krait bite is not 
associated with myonecrosis. The degree of myonecrosis is highest in viper. 
3) There is definite correlation between the severity of myonecrosis and ARF in 
snake bite. 
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APPENDIX I – PROFORMA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SERUM CPK LEVELS IN SNAKE BITE AND CORRELATION WITH ACUTE RENAL FAILURE 
 
NAME:    AGE:      SEX:                OCCUPATION: 
 
ADDRESS:       IP/OP NO: 
 
CLINICAL HISTORY: 
 
TIME/DAY OF BITE    TYPE OF THE SNAKE 
 
PAIN/SWELLING AT THE SITE OF BITE 
 
BLEEDING MANIFESTATIONS  NEUROTOXIC SYMPTOMS 
 
 
 
 
 
SEVERE MYALGIA 
 
OLIGURIA/HEMATURIA/PEDAL EDEMA/FACIAL PUFFINESS 
 
 
CLINICAL EXAMINATION: 
 
GEN EXAMN: 
 
 
 
 
VITAL DATA: 
 
PULSE: 
 
BP: 
 
RR: 
 
TEMP: 
 
SYSTEMIC EXAMINATION:     LOCAL EXAMINATION: 
 
CVS:        CELLULITIS 
 
        ACTIVE BLEED 
 
        FANG MARKS 
RS: 
        DISTAL PULSES 
 
ABDOMEN:       GANGRENE 
 
        MUSCLE TENDERNESS 
CNS: 
 
  
INVESTIGATIONS 
 
Hb % 
 
TC 
 
DC 
 
URINE ALBUMIN 
 SUGAR 
 DEPOSITS 
 MYOGLOBINURIA 
 
 
PARAMETERS/DAY    
BLOOD SUGAR    
BLOOD UREA    
SERUM 
CREATININE 
   
 
 
SERUM 
CPK/DAY 
   
TOTAL    
MM    
 
CLOTTING TIME: 
 
TIME/DAY     
     
     
     
     
 
ECG IN ALL LEADS: 
 
 
 
  
 
 
 
 
 
 
 
 
APPENDIX II MASTER CHART 
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1 Kirupanandham 13 Male Viper + + 2102 5 + Increase 
2 Thangavelu 45 Male Viper - + 372 1 - N 
3 Paramasamy 34 Male Cobra - - 92 NORMAL - N 
4 Malaiyappan 31 Male Viper - + 340 1 - N 
5 Thangam 38 Male Viper - + 628 2 - N 
6 Chinnaadaikkan 78 Male Viper - + 456 1 - N 
7 Rameshbabu 17 Male Viper - + 701 2 - N 
8 Ramasamy 55 Male Viper - - 82 NORMAL - N 
9 Azhagu 41 Male Viper - + 400 1 - N 
10 Ramar 48 Male Unknown - + 358 1 - N 
11 Ganesan 20 Male Cobra - - 88 NORMAL - N 
12 Karuppaiya 37 Male Viper - + 456 1 - N 
13 Mayandi 42 Male Viper - + 458 1 - N 
14 Muthu 23 Male Unknown - + 401 1 - N 
15 Azhagu 25 Male Viper - + 791 2 - N 
16 Ramu 55 Male Viper - + 740 2 - N 
17 Perumayee 33 Female Krait - - 96 NORMAL - N 
18 Arumugam 50 Female Viper - + 452 1 - N 
19 Balamurugan 14 Male Viper - + 701 2 - N 
20 Venkatesh 21 Male Unknown - - 109 NORMAL - N 
21 Chitra 25 Female Viper - + 1301 3 - N 
22 Valli 45 Female Krait - - 96 NORMAL - N 
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23 Alagarsamy 29 Male Viper - + 842 2 - N 
24 Ganapathy 60 Male Viper - + 654 2 - N 
25 Sivanandi 34 Male Viper - + 832 2 - N 
26 Ramasamy 50 Male Viper - + 581 2 - N 
27 Ayyanar 28 Male Viper + + 2162 5 + Increase 
28 Srinivasan 13 Male Unknown - - 112 NORMAL - N 
29 Muthupillai 35 Female Viper + + 2056 5  + Increase 
30 Mariappan 50 Male Unknown - + 642 2 - N 
31 Muthu 37 Female Viper - - 107 NORMAL - N 
32 Ravi 40 Male Viper - + 882 2 - N 
33 Murugesan 27 Male Viper - + 668 2 - N 
34 Petchiammmal 40 Female Viper - + 442 1 - N 
35 Murugaselvam 20 Male unknown + + 2037 5 + Increase 
36 Mookammal 40 Female viper - + 1172 3 - N 
37 Pitchai rajan 24 Male Viper - + 248 1 - N 
38 Sakkarai 45 Male Viper - - 89 NORMAL - N 
39 Muniyandi 53 Male Viper - + 1142 3 - N 
40 Andammal 20 Female Viper - + 315 1 - N 
41 Vasanthi 45 Female Unknown - - 108 NORMAL - N 
42 Jeyaprakash 16 Male Viper - + 358 1 - N 
43 Nagaraj 24 Male Viper - - 91 NORMAL - N 
44 Saravanabalan 30 Male Cobra - + 399 1 - N 
45 Arunkumar 16 Male Viper - + 761 2 - N 
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46 Manickam 42 Male Unknown - + 170 1 - N 
47 Chellakannu 38 Male Viper - + 1871 4 + N 
48 Sonaimuthu 25 Male Viper - + 836 2 - N 
49 Kanthan 35 Male Viper - + 674 2 - N 
50 Govindhan 40 Male Viper - - 56 NORMAL - N 
51 Ravichandran 40 Male Viper - + 396 1 - N 
52 Rajendran 35 Male Unknown - + 273 1 - N 
53 Paulpandy 32 Male Viper - + 177 1 - N 
54 Kalimuthu 40 Male Viper - - 76 NORMAL - N 
55 Kamu 42 Male Viper - + 442 1 - N 
56 Senthilkani 13 Female Viper + + 2032 5 + Increase 
57 Amsam 39 Male Viper - + 316 1 - N 
58 Mangaiyarkarasi 30 Female Viper - + 227 1 - N 
59 Pounraj 45 Male Unknown - - 91 NORMAL - N 
60 Sekar 30 Male Viper - + 1161 3 - N 
61 Ramesh   37 Male Viper - + 1184 3 - N 
62 Perumal  25 Male Unknown + + 1874 4 + Increase 
63 Muniyan  55 Male viper - + 884 2 - N 
64 Ganesh 41 Male Viper - + 232 1 - N 
65 Muthu 55 Male Viper - + 171 1 - N 
66 Vairavan 20 Male Viper - + 475 1 - N 
67 Thangaraj 43 Male Viper - + 507 2 - N 
68 Murugan 30 Male Viper - + 585 2 - N 
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69 Chinnammal 60 Female Viper - - 109 NORMAL - N 
70 Paulkanna 56 Male Viper - + 547 2 - N 
71 Raju 27 Male Viper - + 699 2 - N 
72 Chinnaiya 55 Male Viper - + 788 2 - N 
73 Paramasivam 40 Male Krait - - 108 NORMAL - N 
74 Madhivanan 26 Male Viper + + 2021 5 + Increase 
75 Kazhuvayee 39 Female Viper - + 708 2 - N 
76 Lakshmanan 19 Male Viper - + 696 2 - N 
77 Ochammal 55 Female Unknown - + 750 2 - N 
78 Kannan 30 Male Viper - + 436 1 - N 
79 Venkatesan 36 Male Viper + + 2098 5 + Increase 
80 Lakshmi 33 Female Viper - + 797 2 - N 
81 Ganga 13 Female Viper - + 2031 5 + N 
82 Kannnan 39 Male Viper - + 646 2 - N 
83  Rakku 35 Female Unknown - + 890 2 - N 
84 Muthup andi 30 Female Unknown - + 925 2 - N 
85 Muthu 20 Female Viper - + 674 2 - N 
86 Chinnasamy 32 Male Viper - + 135 NORMAL - N 
87 Manimegalai 14 Female Cobra - + 239 1 - N 
88 Vanitha 22 Female Viper - + 1345 3 - N 
89 Muthupechi 27 Female Viper - + 296 1 - N 
90 Kazhuvayee 40 Female Viper - + 268 1 - N 
91 Selvi 23 Female Viper - + 327 1 - N 
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92 Avudaiachi  48 Female Viper - + 380 1 - N 
93 Alagammal 40 Female Viper - + 234 1 - N 
94 Subramani 25 Male Viper - + 130 NORMAL - N 
95 Perumal  48 Male Viper - + 142 1 - N 
96 Sureshkumar 27 Male Viper - + 281 1 - N 
97 Suresh   41 Male Viper - + 166 1 - N 
98 Mohammed Meeran 17 Male Viper - + 1800 4 - N 
99 Thirumugam 44 Male Viper - + 181 1 - N 
100 Sumathi 27 Female Viper - + 115 NORMAL - N 
 
 
